Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AP Pharma, a specialty pharmaceutical company, has appointed John Whelan as its new vice president of finance and CFO.
Subscribe to our email newsletter
Mr Whelan replaces Gregory Turnbull, who was serving as interim CFO and will remain a company director and a member of the board’s executive committee.
Prior to joining AP Pharma, Mr Whelan was COO and CFO at Raven biotechnologies, where he oversaw the finance function as well as having broad operational responsibilities.
Ronald Prentki, president and CEO of AP Pharma, said: “John’s expertise in financial operations and significant general management experience make him a valuable asset and addition to AP Pharma’s management team.”